Home

MAK Capital Fund reported a 5.8% stake in ADS shares of Autolus Therapeutics AUTL · 15,408,638 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.8%
Last report
First report
Shares held
15,408,638 sh
Class
Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Event date
25/06/17
Filed
25/06/25

First 5%+ report · 5.8% stake

Autolus Therapeutics trades, last 26 weeks

What else happened in Autolus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/18~25/07/17

MAK Capital Fund's other 5% stake reports

  • MAK Capital Fund

    5% stakeComstock

    6.7% stake

    Filed 09/16

  • MAK Capital Fund

    5% stakeStandard Biotools

    6.7% stake

    Filed 05/15

  • MAK Capital Fund

    5% stakeAutolus Therapeutics

    12.6% stake

    Filed 05/15

  • MAK Capital Fund

    5% stakeEvotec

    7.1% stake

    Filed 05/01

  • MAK Capital Fund

    5% stakeEvotec

    7% stake

    Filed 04/06